HEADER BLOOD CLOTTING, HYDROLASE INHIBITOR 25-JUL-08 3DY0 TITLE CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN CAVEAT 3DY0 IDS C 1 HAS WRONG CHIRALITY AT ATOM C4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-TERMINUS PLASMA SERINE PROTEASE INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PPE CLEAVED, RESIDUES 37-372; COMPND 5 SYNONYM: PROTEIN C INHIBITOR, SERPIN A5, PCI, PLASMINOGEN ACTIVATOR COMPND 6 INHIBITOR 3, PAI-3, PAI3, ACROSOMAL SERINE PROTEASE INHIBITOR; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: COMPLEXED WITH HEPARIN FROM BOS TAURUS LUNGS; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: C-TERMINUS PLASMA SERINE PROTEASE INHIBITOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: PPE CLEAVED, RESIDUES 379-406; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SERPINA5, PCI, PLANH3, PROCI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: SERPINA5, PCI, PLANH3, PROCI; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SERPIN, BLOOD CLOTTING, HYDROLASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR W.LI,J.A.HUNTINGTON REVDAT 6 30-AUG-23 3DY0 1 HETSYN REVDAT 5 29-JUL-20 3DY0 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HETNAM LINK SITE ATOM REVDAT 4 13-JUL-11 3DY0 1 VERSN REVDAT 3 14-APR-09 3DY0 1 JRNL REVDAT 2 24-FEB-09 3DY0 1 VERSN REVDAT 1 28-OCT-08 3DY0 0 JRNL AUTH W.LI,J.A.HUNTINGTON JRNL TITL THE HEPARIN BINDING SITE OF PROTEIN C INHIBITOR IS JRNL TITL 2 PROTEASE-DEPENDENT. JRNL REF J.BIOL.CHEM. V. 283 36039 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18974053 JRNL DOI 10.1074/JBC.M805974200 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 953350.010 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 49696 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2500 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 74.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6078 REMARK 3 BIN R VALUE (WORKING SET) : 0.3620 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 313 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2775 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 315 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.79000 REMARK 3 B22 (A**2) : 2.54000 REMARK 3 B33 (A**2) : 0.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.74000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.12 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.190 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.870 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.860 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.780 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 47.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : HEPARIN.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NO3.PAR REMARK 3 PARAMETER FILE 5 : GOL.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : HEPARIN.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NO3.TOP REMARK 3 TOPOLOGY FILE 5 : GOL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3DY0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048630. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49709 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 34.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : 0.05100 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.29600 REMARK 200 R SYM FOR SHELL (I) : 0.29600 REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1LQ8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.12M LITHIUM NITRATE, 12% PEG 3350, REMARK 280 25% GLYCEROL, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.72550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 18 REMARK 465 ALA A 19 REMARK 465 THR A 20 REMARK 465 VAL A 21 REMARK 465 ALA A 22 REMARK 465 PRO A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 ARG B 359 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 26 N CA CB CG CD NE CZ REMARK 470 ARG A 26 NH1 NH2 REMARK 470 LEU A 80 CG CD1 CD2 REMARK 470 LYS A 82 CG CD CE NZ REMARK 470 GLN A 101 CG CD OE1 NE2 REMARK 470 LEU A 118 CG CD1 CD2 REMARK 470 ARG A 144 CD NE CZ NH1 NH2 REMARK 470 LYS A 162 CE NZ REMARK 470 ASP A 173 CG OD1 OD2 REMARK 470 SER A 174 OG REMARK 470 ASN A 175 CG OD1 ND2 REMARK 470 LYS A 197 CG CD CE NZ REMARK 470 GLU A 209 CD OE1 OE2 REMARK 470 LYS A 266 CE NZ REMARK 470 LYS A 297 CD CE NZ REMARK 470 SER B 360 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 43 16.92 58.02 REMARK 500 SER A 66 -131.73 38.51 REMARK 500 SER A 66 -131.74 38.51 REMARK 500 SER A 174 -17.61 105.35 REMARK 500 SER A 232 68.87 71.41 REMARK 500 SER A 305 -40.77 -132.16 REMARK 500 ASP B 375 75.84 -162.31 REMARK 500 ASN B 376 17.87 58.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 IDS C 1 REMARK 610 IDS C 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LQ8 RELATED DB: PDB REMARK 900 ORIGINAL APO STRUCTURE OF CLEAVED PCI DBREF 3DY0 A 18 353 UNP P05154 IPSP_HUMAN 37 372 DBREF 3DY0 B 360 387 UNP P05154 IPSP_HUMAN 379 406 SEQADV 3DY0 ARG B 359 UNP P05154 CLONING ARTIFACT SEQRES 1 A 336 GLY ALA THR VAL ALA PRO SER SER ARG ARG ASP PHE THR SEQRES 2 A 336 PHE ASP LEU TYR ARG ALA LEU ALA SER ALA ALA PRO SER SEQRES 3 A 336 GLN ASN ILE PHE PHE SER PRO VAL SER ILE SER MET SER SEQRES 4 A 336 LEU ALA MET LEU SER LEU GLY ALA GLY SER SER THR LYS SEQRES 5 A 336 MET GLN ILE LEU GLU GLY LEU GLY LEU ASN LEU GLN LYS SEQRES 6 A 336 SER SER GLU LYS GLU LEU HIS ARG GLY PHE GLN GLN LEU SEQRES 7 A 336 LEU GLN GLU LEU ASN GLN PRO ARG ASP GLY PHE GLN LEU SEQRES 8 A 336 SER LEU GLY ASN ALA LEU PHE THR ASP LEU VAL VAL ASP SEQRES 9 A 336 LEU GLN ASP THR PHE VAL SER ALA MET LYS THR LEU TYR SEQRES 10 A 336 LEU ALA ASP THR PHE PRO THR ASN PHE ARG ASP SER ALA SEQRES 11 A 336 GLY ALA MET LYS GLN ILE ASN ASP TYR VAL ALA LYS GLN SEQRES 12 A 336 THR LYS GLY LYS ILE VAL ASP LEU LEU LYS ASN LEU ASP SEQRES 13 A 336 SER ASN ALA VAL VAL ILE MET VAL ASN TYR ILE PHE PHE SEQRES 14 A 336 LYS ALA LYS TRP GLU THR SER PHE ASN HIS LYS GLY THR SEQRES 15 A 336 GLN GLU GLN ASP PHE TYR VAL THR SER GLU THR VAL VAL SEQRES 16 A 336 ARG VAL PRO MET MET SER ARG GLU ASP GLN TYR HIS TYR SEQRES 17 A 336 LEU LEU ASP ARG ASN LEU SER CYS ARG VAL VAL GLY VAL SEQRES 18 A 336 PRO TYR GLN GLY ASN ALA THR ALA LEU PHE ILE LEU PRO SEQRES 19 A 336 SER GLU GLY LYS MET GLN GLN VAL GLU ASN GLY LEU SER SEQRES 20 A 336 GLU LYS THR LEU ARG LYS TRP LEU LYS MET PHE LYS LYS SEQRES 21 A 336 ARG GLN LEU GLU LEU TYR LEU PRO LYS PHE SER ILE GLU SEQRES 22 A 336 GLY SER TYR GLN LEU GLU LYS VAL LEU PRO SER LEU GLY SEQRES 23 A 336 ILE SER ASN VAL PHE THR SER HIS ALA ASP LEU SER GLY SEQRES 24 A 336 ILE SER ASN HIS SER ASN ILE GLN VAL SER GLU MET VAL SEQRES 25 A 336 HIS LYS ALA VAL VAL GLU VAL ASP GLU SER GLY THR ARG SEQRES 26 A 336 ALA ALA ALA ALA THR GLY THR ILE PHE THR PHE SEQRES 1 B 29 ARG SER GLN ARG LEU VAL PHE ASN ARG PRO PHE LEU MET SEQRES 2 B 29 PHE ILE VAL ASP ASN ASN ILE LEU PHE LEU GLY LYS VAL SEQRES 3 B 29 ASN ARG PRO HET IDS C 1 13 HET SGN C 2 19 HET IDS C 3 16 HET SGN C 4 19 HET IDS C 5 11 HET NO3 A 507 4 HET NO3 B 508 4 HET GOL B 506 6 HETNAM IDS 2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D-GLUCOPYRANOSE HETNAM NO3 NITRATE ION HETNAM GOL GLYCEROL HETSYN IDS O2-SULFO-GLUCURONIC ACID; 2-O-SULFO-ALPHA-L-IDURONIC HETSYN 2 IDS ACID; 2-O-SULFO-L-IDURONIC ACID; 2-O-SULFO-IDURONIC HETSYN 3 IDS ACID HETSYN SGN N,O6-DISULFO-GLUCOSAMINE; 6-O-SULFO-N-SULFO-ALPHA-D- HETSYN 2 SGN GLUCOSAMINE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETSYN 3 SGN GLUCOSE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-D-GLUCOSE; HETSYN 4 SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-GLUCOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 IDS 3(C6 H10 O10 S) FORMUL 3 SGN 2(C6 H13 N O11 S2) FORMUL 4 NO3 2(N O3 1-) FORMUL 6 GOL C3 H8 O3 FORMUL 7 HOH *315(H2 O) HELIX 1 1 ASP A 28 ALA A 41 1 14 HELIX 2 2 SER A 49 GLY A 63 1 15 HELIX 3 3 GLY A 65 LEU A 76 1 12 HELIX 4 4 GLN A 81 LEU A 99 1 19 HELIX 5 5 GLN A 123 LEU A 135 1 13 HELIX 6 6 ASP A 145 THR A 161 1 17 HELIX 7 7 ASN A 195 THR A 199 5 5 HELIX 8 8 LYS A 255 LEU A 263 1 9 HELIX 9 9 SER A 264 PHE A 275 1 12 HELIX 10 10 GLU A 296 GLY A 303 5 8 HELIX 11 11 SER A 305 THR A 309 5 5 SHEET 1 A 7 ILE A 46 PHE A 48 0 SHEET 2 A 7 ILE B 378 VAL B 384 -1 O LEU B 381 N PHE A 48 SHEET 3 A 7 PHE B 369 VAL B 374 -1 N PHE B 369 O VAL B 384 SHEET 4 A 7 THR A 245 PRO A 251 -1 N THR A 245 O VAL B 374 SHEET 5 A 7 CYS A 233 PRO A 239 -1 N VAL A 238 O ALA A 246 SHEET 6 A 7 VAL A 211 ASP A 228 -1 N ASP A 228 O CYS A 233 SHEET 7 A 7 GLN A 200 TYR A 205 -1 N GLN A 200 O MET A 216 SHEET 1 B 8 ILE A 46 PHE A 48 0 SHEET 2 B 8 ILE B 378 VAL B 384 -1 O LEU B 381 N PHE A 48 SHEET 3 B 8 PHE B 369 VAL B 374 -1 N PHE B 369 O VAL B 384 SHEET 4 B 8 THR A 245 PRO A 251 -1 N THR A 245 O VAL B 374 SHEET 5 B 8 CYS A 233 PRO A 239 -1 N VAL A 238 O ALA A 246 SHEET 6 B 8 VAL A 211 ASP A 228 -1 N ASP A 228 O CYS A 233 SHEET 7 B 8 LYS A 276 PRO A 285 -1 O LYS A 276 N TYR A 225 SHEET 8 B 8 GLN B 361 VAL B 364 1 O GLN B 361 N GLU A 281 SHEET 1 C 6 ASP A 137 PRO A 140 0 SHEET 2 C 6 GLN A 107 THR A 116 1 N LEU A 114 O ASP A 137 SHEET 3 C 6 ALA A 176 LYS A 189 -1 O VAL A 181 N ALA A 113 SHEET 4 C 6 GLY A 340 THR A 352 -1 O PHE A 351 N VAL A 178 SHEET 5 C 6 GLN A 324 VAL A 336 -1 N VAL A 329 O GLY A 348 SHEET 6 C 6 PHE A 287 GLN A 294 -1 N PHE A 287 O VAL A 336 LINK O4 IDS C 1 C1 SGN C 2 1555 1555 1.41 LINK O4 SGN C 2 C1 IDS C 3 1555 1555 1.40 LINK O4 IDS C 3 C1 SGN C 4 1555 1555 1.41 LINK O4 SGN C 4 C1 IDS C 5 1555 1555 1.40 CRYST1 61.051 49.451 64.969 90.00 113.08 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016380 0.000000 0.006980 0.00000 SCALE2 0.000000 0.020222 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016731 0.00000